Clinical Trials Directory

Trials / Completed

CompletedNCT01899677

The Efficacy of Symbiotic on Cytokines

The Efficacy of Symbiotic Preparation on Cytokines Which Act on Necrotising Enterocolitis Pathogenesis in Very Low Birth Weight Infants

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Academic / Other
Sex
All
Age
1 Hour – 2 Days
Healthy volunteers
Accepted

Summary

The aim of this prospective double blinded randomised study is to investigate the efficacy of symbiotic preparation which contains lactobacillus casei, L. rhamnosus, L. plantarum, Bifidobacterium lactis, fructo and galactooligosaccharide on cytokines as interferon-gama acting on Th1 pathway, interleukin -5 acting on Th2, interleukin -10 acting on T regulatory pathway, and interleukin -17 acting on Th-17 pathway that were related with necrotizing enterocolitis pathogenesis in very low birth weight neonates.

Detailed description

Inclusion criteria: 1. Neonates who born 26- 32 gestational week and 750-1500 gram birth weights 2. Neonates who tolerated minimal enteral feeding within postnatal first week Exclusion criteria: 1. PROM\> 24 hours and/or chorioamnionitis 2. Mechanic ventilation supply more than 7 days 3. Culture proven sepsis 4. Major congenital anomaly 5. Patients undergoing surgery Intervention: The allocations will contain in opaque, sequentially numbered sealed envelopes. The study group will receive symbiotic preparation (Probiotic ATP, Nobel, 1/2 sachet twice daily); whereas the control group will receive placebo (distilled water; 1 ml per dose twice daily) which will be added to breast milk or formula starting with the first feed.0.5 cc blood sampling will be taken from patients within postnatal 48 hours, 14+2.days, 28+2.days. This samples will turn by cold centrifugation and store at -20 °C temperature. The cytokines will be analysed by ELISA multiplex method.

Conditions

Interventions

TypeNameDescription
OTHERdistilled water0.5 cc distilled water twice daily will be added to the breast milk or formula during 30 days
DRUGsymbioticSymbiotic 1/2 sachet twice daily will be added to the breast milk or formula during 30 days

Timeline

Start date
2013-07-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2013-07-15
Last updated
2014-08-08
Results posted
2014-08-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01899677. Inclusion in this directory is not an endorsement.